Harada, Y. ., Nagata, Y. ., Kihara, R. ., Ishikawa, Y. ., Asou, N. ., Ohtake, S. ., … Group, J. J. A. L. S. (2018). Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study. Leukemia Research, 66, 20-27. https://doi.org/10.1016/j.leukres.2018.01.008 (Original work published 2018)

Ishikawa, J. ., Matsumura, I. ., Kawaguchi, T. ., Kuroda, J. ., Nakamae, H. ., Miyamoto, T. ., … Kanakura, Y. . (2018). Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial). International Journal of Hematology. https://doi.org/10.1007/s12185-018-2401-y (Original work published 2018)